Company profile Β· AI Β· Voice

ElevenLabs

Premium$22Bβ‰ˆ2Γ— the Feb 2026 round ($11B)

About

ElevenLabs builds AI voice-generation and dubbing technology β€” synthetic speech used for audiobooks, video localization, and conversational agents. It is one of the fastest-growing generative-AI startups by revenue.

Premium or discount?

Every secondary transaction reported for ElevenLabs has priced above its prior primary round β€” most recently a discussed valuation roughly 2Γ— its February 2026 mark β€” reflecting sustained buyer demand for a category leader in applied AI.

How to read this record

Two entries here, and only one of them is a completed transaction. The May 2025 event was a $100M staff sale that actually cleared, at roughly twice the January 2025 round. The 2026 entry at $22B is a reported discussion, not a closed and priced deal β€” sourced to press reporting rather than to a settled trade. The distinction matters: a discussed valuation is an ask, and an ask is where a process starts, not where it ends. Until a tender prices, treat the $22B as a negotiating position that a buyer pool has not yet tested.

Getting exposure from Latin America

Neither event in this record was open to outside buyers. Both were company-organised sales of employee stock, and the buy side was invited. An investor in SΓ£o Paulo or Mexico City reaching for this exposure is therefore looking at third-party routes β€” an SPV assembled by a broker, or a fund that already holds a position β€” with fees stacked at each layer and no information rights over the underlying company. In a name re-pricing this quickly, the fee drag matters less than the entry mark: paying the discussed number rather than the last cleared one is the real risk.

Secondary deal history

DateValuationvs. last roundTypeBuyersSource
Jul 2026$22BPremiumβ‰ˆ2Γ— the Feb 2026 round ($11B)Tender offer (in discussion)Reported, not disclosedInvesting.com / Bloomberg β†—
May 2025$6.6BPremium$100M staff sale, above the Jan 2025 round ($3.3B)Employee secondary saleNot disclosedCitrine Capital β†—

Frequently asked questions

Can I buy secondary shares in ElevenLabs?
Retail investors generally cannot buy shares directly. Access typically runs through accredited-investor marketplaces, employee tender programs, or funds that have already built a position β€” and is subject to the company’s transfer restrictions and rights of first refusal.
Why did ElevenLabs's valuation trade at a premium to its last round?
Every secondary transaction reported for ElevenLabs has priced above its prior primary round β€” most recently a discussed valuation roughly 2Γ— its February 2026 mark β€” reflecting sustained buyer demand for a category leader in applied AI.
Is the valuation on this page an official company valuation?
No. Secondary marks reflect the price a buyer and seller agreed on in a specific transaction, not a valuation the company itself set. They are a useful demand signal, not an audited or company-endorsed figure.